U.S. healthcare affordability crisis deepens: systemic underfunding and privatization drive 50% access decline since 2020
Original framing: “How many Americans can afford high-quality health care? A new poll finds the number has fallen” — STAT News
Peer-reviewed studies (e.g., *The Lancet*’s 2020 U.S. healthcare ranking) show the U.S. spends 2x per capita on healthcare as peer nations but ranks last in access, equity, and outcomes. Administrative waste accounts for $265B annually (12% of total spending), while pharmaceutical price-gouging (e.g., insulin costs 10x in the U.S. vs. Canada) is enabled by patent monopolies and PBM rebate schemes. The scientific consensus supports single-payer as the most cost-effective path to universal coverage.
The U.S. healthcare affordability crisis is not a market failure but a designed outcome of neoliberal policy, where corporations extract value while communities suffer.
Decades of deregulation, patent monopolies, and employer-based insurance have created a system where 50% of adults cannot access care—a statistic that reflects the triumph of shareholder primacy over human dignity. Indigenous and global models (e.g., Kerala’s integrative care, Māori *whānau* systems) prove that decolonized, publicly accountable healthcare is not only possible but more cost-effective. The path forward requires dismantling the financialization of health, reinvesting in community-rooted systems, and centering marginalized voices in design. As trickster narratives remind us, the absurdity of a system that bills suffering as profit is not a bug but a feature—one that demands we invert the logic entirely. The tools exist; the political will must be forged.